The sudden infant death syndrome (SIDS) is the leading cause of postneonatal death in the United States, with an incidence of 1.5/1000 live births. We propose to focus upon the most promising lead that has emerged from our studies in SIDS brains: a deficiency of muscarinic cholinergic receptor binding in the arcuate nucleus of the ventral surface of the medulla. Our overall hypothesis that SIDS, or a subset of SIDS, is due to abnormality of the arcuate nucleus, a component of the ventral surface cell populations of the medulla which are putatively involved in chemosensitivity to carbon dioxide and hydrogen ion, cardiopulmonary coupling, and pressor responses. This abnormality results in a failure of the affected infant to respond to a life-threatening challenge, such as hypercarbia or asphyxia, during sleep, and leads to sleep-related sudden death during a vulnerable period in the development of homeostatic control.
Our SPECIFIC AIMS over the next 4 years are: l. To test the hypothesis that the neurotransmitter abnormality in the arcuate nucleus in SIDS victims is confined to the muscarinic cholinergic receptor. This study will be done by determining if there is an abnormality in serotoninergic, kainate, or GABAergic binding, three other markers of the arcuate nucleus, in SIDS victims compared to age-matched controls using quantitative receptor autoradiography. 2. To test the hypothesis that there is altered serotoninergic binding in the caudal raphe of SIDS victims compared to aged-matched controls. We have preliminary evidence that the human arcuate nucleus is interconnected with the caudal raphe. Animal studies indicate the caudal raphe and its major neurotransmitter serotonin is involved in cardioventilatory function, and that the caudal raphe projects to medullary and cord nuclei critical to cardioventilatory regulation. This study will be done using 3H-LSD binding to serotoninergic receptors. 3. To characterize further the cholinergic anatomy of the developing human arcuate nucleus. 4. To characterize further receptor binding patterns to selected neurotransmitters and neuromodulators which are postulated to be involved in ventral surface function in animals. 5. To determine the connections of the human arcuate nucleus and its pre- and postnatal development using the fluorescent tracer DiI to label projections in postmortem brainstem tissues. At the end of the 4-year period, this grant should lead to a greater understanding of the role of the human arcuate nucleus in SIDS. It should also provide a solid anatomic foundation for hypothesis-driven experiments in an animal model for SIDS based upon a muscarinic cholinergic defect in the immature ventral medullary surface.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD020991-11
Application #
2392367
Study Section
Human Embryology and Development Subcommittee 1 (HED)
Project Start
1992-09-01
Project End
2000-03-31
Budget Start
1997-04-01
Budget End
1998-03-31
Support Year
11
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Haynes, Robin L; Frelinger 3rd, Andrew L; Giles, Emma K et al. (2017) High serum serotonin in sudden infant death syndrome. Proc Natl Acad Sci U S A 114:7695-7700
Edlow, Brian L; Haynes, Robin L; Takahashi, Emi et al. (2013) Disconnection of the ascending arousal system in traumatic coma. J Neuropathol Exp Neurol 72:505-23
Randall, Bradley B; Paterson, David S; Haas, Elisabeth A et al. (2013) Potential asphyxia and brainstem abnormalities in sudden and unexpected death in infants. Pediatrics 132:e1616-25
Kinney, Hannah C; McDonald, Anna G; Minter, Megan E et al. (2013) Witnessed sleep-related seizure and sudden unexpected death in infancy: a case report. Forensic Sci Med Pathol 9:418-21
Paterson, David S (2013) Serotonin gene variants are unlikely to play a significant role in the pathogenesis of the sudden infant death syndrome. Respir Physiol Neurobiol 189:301-14
Haynes, Robin L; van Leyen, Klaus (2013) 12/15-lipoxygenase expression is increased in oligodendrocytes and microglia of periventricular leukomalacia. Dev Neurosci 35:140-54
Cummings, Kevin J; Commons, Kathryn G; Trachtenberg, Felicia L et al. (2013) Caffeine improves the ability of serotonin-deficient (Pet-1-/-) mice to survive episodic asphyxia. Pediatr Res 73:38-45
Serang, Oliver; Froehlich, John W; Muntel, Jan et al. (2013) SweetSEQer, simple de novo filtering and annotation of glycoconjugate mass spectra. Mol Cell Proteomics 12:1735-40
McDowell, Gary S; Gaun, Aleksandr; Steen, Hanno (2013) iFASP: combining isobaric mass tagging with filter-aided sample preparation. J Proteome Res 12:3809-12
Broadbelt, Kevin G; Rivera, Keith D; Paterson, David S et al. (2012) Brainstem deficiency of the 14-3-3 regulator of serotonin synthesis: a proteomics analysis in the sudden infant death syndrome. Mol Cell Proteomics 11:M111.009530

Showing the most recent 10 out of 49 publications